Jeffrey Del Carmen is Chief Commercial Officer of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 30,423 shares of CPRX, which is worth approximately $679,041. The most recent transaction as insider was on Jun 24, 2021, when has been sold 10,000 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.4K
145.96% 3M change
17.16% 12M change
Total Value Held $679,041

Jeffrey Del Carmen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 24 2021
BUY
Exercise of conversion of derivative security
-
10,000 Added 50.0%
10,000 Common Stock, par valu...
JDC

Jeffrey Del Carmen

Chief Commercial Officer
Coral Gables, FL

Track Institutional and Insider Activities on CPRX

Follow CATALYST PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX